MoneyWorks4Me

Makers Laboratories - Quaterly Results

13 Feb 2023 Evaluate
A decrease in the sales to Rs. 106.25 millions was observed for the quarter ended December 2022. The sales stood at Rs. 135.09 millions during the similar quarter previous year.The Net Loss for the quarter ended December 2022 is Rs. -25.69 millions as compared to Net Profit of Rs. 6.67 millions of corresponding quarter ended December 2021Operating profit Margin for the quarter ended December 2022 slipped to -17.09% as compared to 14.64% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 106.25 135.09 -21.35 317.04 433.82 -26.92 524.09 444.11 18.01
Other Income 1.35 0.41 229.27 9.57 7.65 25.10 8.48 4.14 104.83
PBIDT -17.09 14.64 -216.73 -29.97 48.43 -161.88 38.95 37.11 4.96
Interest 4.03 3.89 3.60 10.99 12.80 -14.14 16.75 15.89 5.41
PBDT -21.12 10.75 -296.47 -40.96 35.63 -214.96 22.20 21.22 4.62
Depreciation 6.64 4.75 39.79 17.44 14.36 21.45 19.07 41.96 -54.55
PBT -27.76 6.00 -562.67 -58.40 21.27 -374.57 3.13 -20.74 -115.09
TAX -2.07 -0.67 208.96 -2.85 3.52 -180.97 1.41 -4.57 -130.85
Deferred Tax -2.07 0.78 -365.38 -2.85 2.67 -206.74 1.08 -2.90 -137.24
PAT -25.69 6.67 -485.16 -55.55 17.75 -412.96 1.72 -16.17 -110.64
Equity 59.00 49.17 19.99 59.00 49.17 19.99 49.17 49.17 0.00
PBIDTM(%) -16.08 10.84 -248.42 -9.45 11.16 -184.68 7.43 8.36 -11.06
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..